RhumbLine Advisers’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $134K | Sell |
|
|||||
|
2024
Q4 | $279K | Buy |
|
|||||
|
2024
Q3 | $319K | Sell |
|
|||||
|
2024
Q2 | $385K | Buy |
|
|||||
|
2024
Q1 | $1.3M | Buy |
|
|||||
|
2023
Q4 | $1.22M | Sell |
|
|||||
|
2023
Q3 | $1.62M | Buy |
|
|||||
|
2023
Q2 | $1.88M | Buy |
|
|||||
|
2023
Q1 | $1.11M | Buy |
|
|||||
|
2022
Q4 | $1.17M | Buy |
|
|||||
|
2022
Q3 | $1.19M | Buy |
|
|||||
|
2022
Q2 | $1.28M | Buy |
|
|||||
|
2022
Q1 | $1.75M | Buy |
|
|||||
|
2021
Q4 | $2.98M | Buy |
|
|||||
|
2021
Q3 | $2.31M | Buy |
|
|||||
|
2021
Q2 | $1.7M | Buy |
|
|||||
|
2021
Q1 | $1.33M | Sell |
|
|||||
|
2020
Q4 | $1.69M | Buy |
|
|||||
|
2020
Q3 | $396K | Sell |
|
|||||
|
2020
Q2 | $631K | Buy |
|